• Je něco špatně v tomto záznamu ?

Bile acids decrease intracellular bilirubin levels in the cholestatic liver: implications for bile acid-mediated oxidative stress

L. Muchova, K. Vanova, J. Zelenka, M. Lenicek, T. Petr, M. Vejrazka, E. Sticova, HJ. Vreman, RJ. Wong, L. Vitek,

. 2011 ; 15 (5) : 1156-65.

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc12028496

Grantová podpora
NR9366 MZ0 CEP - Centrální evidence projektů

High plasma concentrations of bile acids (BA) and bilirubin are hallmarks of cholestasis. BA are implicated in the pathogenesis of cholestatic liver damage through mechanisms involving oxidative stress, whereas bilirubin is a strong antioxidant. We evaluated the roles of bilirubin and BA on mediating oxidative stress in rats following bile duct ligation (BDL). Adult female Wistar and Gunn rats intraperitoneally anaesthetized with ketamine and xylazine underwent BDL or sham operation. Cholestatic markers, antioxidant capacity, lipid peroxidation and heme oxygenase (HO) activity were determined in plasma and/or liver tissue 5 days after surgery. HepG2-rNtcp cells were used for in vitro experiments. Plasma bilirubin levels in control and BDL animals positively correlated with plasma antioxidant capacity. Peroxyl radical scavenging capacity was significantly higher in the plasma of BDL Wistar rats (210 ± 12%, P < 0.0001) compared to controls, but not in the liver tissues. Furthermore after BDL, lipid peroxidation in the livers increased (179 ± 37%, P < 0.01), whereas liver HO activity significantly decreased to 61% of control levels (P < 0.001). Addition of taurocholic acid (TCA, ≥ 50 μmol/l) to liver homogenates increased lipid peroxidation (P < 0.01) in Wistar, but not in Gunn rats or after the addition of bilirubin. In HepG2-rNtcp cells, TCA decreased both HO activity and intracellular bilirubin levels. We conclude that even though plasma bilirubin is a marker of cholestasis and hepatocyte dysfunction, it is also an endogenous antioxidant, which may counteract the pro-oxidative effects of BA in circulation. However, in an animal model of obstructive cholestasis, we found that BA compromise intracellular bilirubin levels making hepatocytes more susceptible to oxidative damage.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12028496
003      
CZ-PrNML
005      
20171031150643.0
007      
ta
008      
120817s2011 enk f 000 0eng||
009      
AR
024    7_
$a 10.1111/j.1582-4934.2010.01098.x $2 doi
035    __
$a (PubMed)20518850
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Muchova, Lucie $u Institute of Clinical Biochemistry and Laboratory Diagnostics, Charles University, Prague, Czech Republic. lucie.muchova@lf1.cuni.cz
245    10
$a Bile acids decrease intracellular bilirubin levels in the cholestatic liver: implications for bile acid-mediated oxidative stress / $c L. Muchova, K. Vanova, J. Zelenka, M. Lenicek, T. Petr, M. Vejrazka, E. Sticova, HJ. Vreman, RJ. Wong, L. Vitek,
520    9_
$a High plasma concentrations of bile acids (BA) and bilirubin are hallmarks of cholestasis. BA are implicated in the pathogenesis of cholestatic liver damage through mechanisms involving oxidative stress, whereas bilirubin is a strong antioxidant. We evaluated the roles of bilirubin and BA on mediating oxidative stress in rats following bile duct ligation (BDL). Adult female Wistar and Gunn rats intraperitoneally anaesthetized with ketamine and xylazine underwent BDL or sham operation. Cholestatic markers, antioxidant capacity, lipid peroxidation and heme oxygenase (HO) activity were determined in plasma and/or liver tissue 5 days after surgery. HepG2-rNtcp cells were used for in vitro experiments. Plasma bilirubin levels in control and BDL animals positively correlated with plasma antioxidant capacity. Peroxyl radical scavenging capacity was significantly higher in the plasma of BDL Wistar rats (210 ± 12%, P < 0.0001) compared to controls, but not in the liver tissues. Furthermore after BDL, lipid peroxidation in the livers increased (179 ± 37%, P < 0.01), whereas liver HO activity significantly decreased to 61% of control levels (P < 0.001). Addition of taurocholic acid (TCA, ≥ 50 μmol/l) to liver homogenates increased lipid peroxidation (P < 0.01) in Wistar, but not in Gunn rats or after the addition of bilirubin. In HepG2-rNtcp cells, TCA decreased both HO activity and intracellular bilirubin levels. We conclude that even though plasma bilirubin is a marker of cholestasis and hepatocyte dysfunction, it is also an endogenous antioxidant, which may counteract the pro-oxidative effects of BA in circulation. However, in an animal model of obstructive cholestasis, we found that BA compromise intracellular bilirubin levels making hepatocytes more susceptible to oxidative damage.
650    _2
$a zvířata $7 D000818
650    _2
$a žlučové kyseliny a soli $x metabolismus $7 D001647
650    _2
$a bilirubin $x metabolismus $7 D001663
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a cholestáza $x metabolismus $x patologie $7 D002779
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a hemová oxygenasa (decyklizující) $x krev $7 D006419
650    _2
$a lidé $7 D006801
650    _2
$a intracelulární prostor $x metabolismus $7 D042541
650    _2
$a peroxidace lipidů $x účinky léků $7 D015227
650    _2
$a játra $x metabolismus $x patologie $7 D008099
650    _2
$a oxidační stres $x účinky léků $7 D018384
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Gunn $7 D011911
650    _2
$a potkani Wistar $7 D017208
650    _2
$a kyselina taurocholová $x farmakologie $7 D013656
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Vanova, Katerina
700    1_
$a Zelenka, Jaroslav
700    1_
$a Lenicek, Martin
700    1_
$a Petr, Tomas
700    1_
$a Vejrazka, Martin
700    1_
$a Sticova, Eva
700    1_
$a Vreman, Hendrik Jan
700    1_
$a Wong, Ronald James
700    1_
$a Vitek, Libor
773    0_
$w MED00006785 $t Journal of cellular and molecular medicine $x 1582-4934 $g Roč. 15, č. 5 (2011), s. 1156-65
856    41
$u https://pubmed.ncbi.nlm.nih.gov/20518850 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m $z 0
990    __
$a 20120817 $b ABA008
991    __
$a 20171031150733 $b ABA008
999    __
$a ok $b bmc $g 950538 $s 785842
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2011 $b 15 $c 5 $d 1156-65 $i 1582-4934 $m Journal of cellular and molecular medicine $n J Cell Mol Med $x MED00006785
GRA    __
$a NR9366 $p MZ0
LZP    __
$a Pubmed-20120817/11/04

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...